Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 2, 2011, Pages 648-649

  Ekinci, Ozalp ^a   Sabuncuoglu, Osman ^b  

^a Antakya State Hospital of Obstetrics and Child Care   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; METHYLPHENIDATE; RISPERIDONE;

ADOLESCENT; AGGRESSION; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CASE REPORT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVENING DOSAGE; HUMAN; IMPULSIVENESS; LETTER; MALE; PSYCHOSIS;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; MALE; METHYLPHENIDATE; PIPERAZINES; PSYCHOSES, SUBSTANCE-INDUCED; QUINOLONES; RISPERIDONE;

EID: 79952901655     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.11.039     Document Type: Letter

References (10)

1. Cohen L.J. Risperidone. Pharmacotherapy 1994, 14:253-265.
2. DeLeon A., Patel N.C., Crismon M.L. Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy and tolerability. Clin Ther 2004, 26:649-666.
3. Findling R.L., Short E.J., Leskovec T., Townsend L.D., Demeter C.A., McNamara N.K., Stansbrey R.J. Aripiprazole in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2008, 18:347-354.
4. Greenaway M., Elbe D. Focus on aripiprazole: a review of its use in child and adolescent psychiatry. J Can Acad Child Adolesc Psychiatry 2009, 18:250-260.
5. Kapusta N.D., Mossaheb N., Barnas C., Fischer P. Aripiprazole-induced psychosis: a case report of reexposure by stepwise up-titration. J Clin Psychiatry 2007, 68:1445-1446.
6. Kuczenski R., Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 1997, 68:2032-2037.
7. Ramaswamy S., Vijay D., William M., Sattar S.P., Praveen F., Petty F. Aripiprazole possibly worsens psychosis. Int Clin Psychopharmacol 2004, 19:45-48.
8. Silvestri S., Seeman M.V., Negrete J.C., Houle S., Shammi C.M., Remington G.J., et al. Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacol Berl 2000, 152:174-180.
9. Turgay A. Treatment of comorbidity in conduct disorder with attention-deficit hyperactivity disorder (ADHD). Essent Psychopharmacol 2005, 6:277-290.
10. Zeni C.P., Tramontina S., Ketzer C.R., Pheula G.F., Rohde L.A. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. J Child Adolesc Psychopharmacol 2009, 19:553-561.